HomeNDC LookupIngredientsBenzoyl Peroxide › 00536-1055-25
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel — NDC 00536-1055-25 package photo

Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel

by Rugby Laboratories · 1 TUBE in 1 CARTON (0536-1055-25) / 60 mL in 1 TUBE
NDC 00536-1055-25
🏷️ FDA NDC (as labeled) 0536-1055-25 billing pads the labeler segment with a zero
This package
Contains60 mL in 1 tube Cost per g$0.2173 NADAC Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.2701/unit — full pricing hub ↓
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Benzoyl Peroxide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Feb 24, 2025 — Chemical Contamination: Presence of benzene. (Denison Pharmaceuticals, LLC) · FDA recall D-0273-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 0536-1055-25
Product NDC 0536-1055
11-digit billing NDC 00536105525
NCPDP billing unit GM — per gram (weight)
RxCUI 308694
UNII W9WZN9A0GM
Application # M006
SPL Set ID de9ac9fe-b6af-45b7-bbf2-70c47f45885b
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-01-20
Route TOPICAL
Dosage form GEL
Substance BENZOYL PEROXIDE
GPI-14 90050010004010
GPI class Acne Medication 5
GCN Seq No 005813
GCN 22931
HICL code 002470
Ingredient (HICL) Benzoyl Peroxide
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L5
Therapeutic class — intermediate (HIC2) Keratolytics/Keratoplastics
HIC3 code L5A
Therapeutic class — specific (HIC3) Keratolytics
AHFS code 84:28.00.00
AHFS class Keratolytic Agents
FDB label name ACNE MEDICATION 5% GEL
FDB brand name Acne Medication
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0536-1055-25 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1055-25. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Peroxides class.

Drug family (ATC) Peroxides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedJan 2015
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name ACNE MEDICATION 5% GEL Ingredient Benzoyl Peroxide
📖 What it is MedlinePlus · NLM

Benzoyl peroxide is used to treat mild to moderate acne.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Most benzoyl peroxide products are used to treat acne — they clear up pimples, blemishes, blackheads, and whiteheads, and help keep new ones from forming. One prescription product,...
  • What exactly is benzoyl peroxide used for?
  • Yes, some dryness, redness, peeling, and mild irritation are very common, especially when you first start. The best strategy is to begin with just once daily and slowly work up to...
  • My skin got really dry and red after I started using it — is that normal?
📖 Read our full Benzoyl Peroxide guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Benzoyl Peroxide — tap one for details:

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.217
Medicaid paysCMS SDUD · 12 mo $0.2701
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2021 Sep 2022 Jan 2026 Aug 2026 $0.228 $0.194
▼ Down 1% over the last 22 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Benzoyl Peroxide Wash Acne Medication 50 mg/mL 00536-1259-19 Rugby 236 ml $0.028 Availability likely save 87%
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL 00536-1057-75 Rugby 1 tube $0.067 Discontinued save 69%
benzoyl peroxide 5 g/100g 45802-0216-01 Padagis 1 tube $0.179 Availability likely save 17%
Rugby Benzoyl Peroxide Acne Medication 50 mg/mLthis 00536-1055-25 Rugby 1 tube $0.217 Availability likely
Rugby Benzoyl Peroxide Acne Medication 50 mg/g 00536-1467-25 Rugby 1 tube $0.217 Availability likely
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL 50090-1720-00 A-S 1 tube FDA listed
Replenix Acne 50 mg/g 51326-0411-57 Topiderm, 57 g FDA listed
Clear Proof Acne Treatment Acne Medication 5 g/100g 51531-9071-00 Mary 3 g FDA listed
Benzoyl Peroxide Acne Medication 50 mg/mL 68071-2307-05 NuCare 42.5 ml FDA listed
5 Acne Med 50 mg/mL 70707-0155-15 Face 1 tube Discontinued
Acne Med 5% 50 mg/mL 70707-0211-15 Face 1 bottle FDA listed
MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel 50 mg/mL 71399-9478-05 Akron 1 tube FDA listed
HUMANE Acne Spot Treatment 50 mg/mL 73010-0127-00 Apprendista, 1 tube FDA listed
24 Hour Acne Serum 5 g/100g 83286-0007-01 Drmtlgy, 32 g FDA listed
Glytone Acne BPO Treatment Gel .05 g/g 84262-0030-01 Glytone, 60 g FDA listed
ACNE FORTE Acne Treatment Cream 50 mg/mL 52063-0709-00 GSCM 1 jar FDA listed
SERIOUS SKINCARE Continuously Clear Clearz It 50 mg/mL 53755-0392-00 Flageoli 59 ml FDA listed
Acne Treatment 50 mg/mL 67226-2050-03 Vivier 1 tube FDA listed
MD-Acne Body Acne Treatment 50 mg/mL 71804-0230-06 MD 180 ml FDA listed
Nighttime Control 50 mg/mL 76458-0333-02 Circadia 1 bottle FDA listed
5 Percent Benzoyl Peroxide Cleanser 50 mg/mL 81136-0023-01 Brand 1 tube FDA listed
Walgreens Daily Acne Cleanser- Sensitive Skin Formula 50 mg/mL 00363-5602-01 Walgreen 1 tube FDA listed
MDacne Customized Acne Treatment Benzoyl Peroxide 50 mg/mL 71804-0536-00 MDAlgorithms 1 tube FDA listed
MDacne Body Acne Treatment Benzoyl Peroxide 50 mg/mL 71804-0532-00 MDAlgorithms 90 ml FDA listed
OXY Sensitive Face Wash Maximum Soothing 50 mg/mL 10742-1313-01 The 148 ml FDA listed
Clenziderm Therapeutic 50 mg/mL 62032-0611-01 Obagi 47 ml FDA listed
Face Reality 5% Advanced Acne Med 50 mg/mL 70707-0157-01 Face 1 tube FDA listed
OXY Advanced Care Sensitive Skin Acne Cleanser 50 mg/mL 10742-1203-01 The 148 ml FDA listed
Naturium Benzoyl Peroxide Cleanser 5% 50 mg/mL 76354-0123-01 e.l.f. 1 tube FDA listed
BLAIR and JACK Anti-Bump Acne Treatment 50 mg/mL 84377-0489-00 Blair 1 jar FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Jan 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1055-25, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
4.7K
Units reimbursed last 4 qtrs
283.8K
Gross reimbursed last 4 qtrs
$76.6K
Avg / prescription
$16.36
Avg / unit
$0.2701
Latest quarter Q4 2025
341Rx
Medicaid pays / g
$0.2701
gross reimbursed
vs
NADAC / g
$0.2173
acquisition cost
=
Spread
+$0.0528
+24% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
66% FFS 34% MCO
Fee-for-service · 3,097 Rx Managed care · 1,586 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 2,340 units · 40.8 per 100k residents MN Wisconsin: 5,665 units · 95.9 per 100k residents WI Michigan: 14,340 units · 143 per 100k residents MI New York: 105,452 units · 539 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 840 units · 19.8 per 100k residents OR Nevada: 660 units · 20.7 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 3,420 units · 107 per 100k residents IA Illinois: no data reported IL Indiana: 6,600 units · 96.2 per 100k residents IN Ohio: 22,682 units · 192 per 100k residents OH Pennsylvania: 6,120 units · 47.2 per 100k residents PA New Jersey: 12,360 units · 133 per 100k residents NJ Massachusetts: 3,643 units · 52.0 per 100k residents MA California: 72,704 units · 187 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 5,820 units · 129 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: 3,480 units · 56.3 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 6,450 units · 58.5 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 11,190 units · 36.7 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
19.8539
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 539 /100k
2 Ohio 192 /100k
3 California 187 /100k
4 Michigan 143 /100k
5 New Jersey 133 /100k
6 Kentucky 129 /100k
7 Iowa 107 /100k
8 Indiana 96.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 tube00536-1055-56 53,737 Rx · $546,570
1 tube this page00536-1055-25 4,683 Rx · $76,633
1 tube00536-1055-57 No Medicaid data
Drug total (last 4 qtrs): 58,420 Rx · 2,693,450 units · $623,203 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Epsolay (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Epsolay. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$60.9K
Claims incl. refills
82
Beneficiaries
63
Spend / beneficiary
$967.04
Spend / claim
$742.97
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
00536-1055-25 You're viewing this 1 TUBE in 1 CARTON (0536-1055-25) / 60 mL in 1 TUBE $0.2173 / g 2019-10-31 Active
00536-1055-56 1 TUBE in 1 CARTON (0536-1055-56) / 42.5 mL in 1 TUBE $0.0859 / g 2015-01-20 Active
00536-1055-57 1 TUBE in 1 CARTON (0536-1055-57) / 90 mL in 1 TUBE 2019-10-31 Discontinued by firm

Per g, this pack runs about 153% above the cheapest pack (NDC 00536-1055-56, $0.0859 vs $0.2173 NADAC).

This pack accounts for about 8.0% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in NDC 00536-1055-25?
NDC 00536-1055-25 is listed by the FDA — 1 tube in 1 carton / 60 ml in 1 tube.
What NDC number is used to bill for this package of Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel?
Bill NDC 00536-1055-25 — the 11-digit billing format is 00536105525. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 6 words

Use for the treatment of acne

⏱️ Dosage and Administration 31 words

Directions Cleanse skin thoroughly before applying medication. Cover the entire affected area with a thin layer 1-3 times daily. If bothersome dryness or peeling occurs, reduce application to once a day.

⚠️ Warnings 174 words

Warnings For external use only Do not use this medication if you have very sensitive skin or if you are sensitive to benzoyl peroxide. When using this product n keep away from eyes, lips and mouth avoid unnecessary sun exposure and use a sunscreen avoid contact with hair or dyed fabric, including carpet and clothing which may be bleached by this product skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Mild irritation may be reduced by using the product less frequently or in a lower concentration.

If irritation becomes severe, discontinue use; if irritation still continues, consult a doctor. using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. Avoid contact with the eyes. If contact occurs, flush thoroughly with water.

📦 Storage and Handling 17 words

Other information Keep tightly closed. Avoid storing at extreme temperatures (below 40° F and above 100° F).

🧪 Active Ingredient 8 words

Active ingredient Benzoyl peroxide 5% Purpose Acne treatment

🧪 Inactive Ingredients 11 words

Inactive ingredients carbomer, disodium EDTA, laureth-4, sodium hydroxide, titanium dioxide, water

🎯 Purpose 3 words

Purpose Acne treatment

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.